|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Recro Pharma (NASDAQ: REPH) through any online brokerage.
The latest price target for Recro Pharma (NASDAQ: REPH) was reported by Oppenheimer on May 12, 2020. The analyst firm set a price target for 12.00 expecting REPH to rise to within 12 months (a possible 552.17% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Recro Pharma (NASDAQ: REPH) is $1.84 last updated Thu Jul 29 2021 20:00:03 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Recro Pharma.
There is no upcoming split for Recro Pharma.
Recro Pharma is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.